Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription 20.05.2024 2 Am J Surg Pathol 3 Gynecol Oncol 1 Int J Cancer 3 Int J Gynaecol Obstet 1 Int J Oncol 1 J Clin Oncol 1 Nat Med 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg Pathol

1. ULBRIGHT TM, Acosta AM
   Ovarian Sex Cord Tumor Harboring FUS::CREM Fusion: An Ovarian Counterpart of Inflammatory and Nested Testicular Sex Cord Tumor.
   Am J Surg Pathol. 2024 Apr 8. doi: 10.1097/PAS.0000000000002221.
   PubMed        
   
   
2. SHIBAYAMA T, Hayashi A, Nagahama K, Hibiya T, et al
   Ovarian Sex Cord Tumor Harboring FUS::CREM Fusion: An Ovarian Counterpart of Inflammatory and Nested Testicular Sex Cord Tumor?
   Am J Surg Pathol. 2024 Jan 15. doi: 10.1097/PAS.0000000000002180.
   PubMed        
   
   

   
   Gynecol Oncol

3. LIU JF, Xiong N, Wenham RM, Wahner-Hendrickson A, et al
   A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.
   Gynecol Oncol. 2024;187:105-112.
   PubMed         Abstract available
   
   
4. ROSATI A, De Rose AM, Gallotta V, Giannarelli D, et al
   Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer.
   Gynecol Oncol. 2024;187:98-104.
   PubMed         Abstract available
   
   
5. FILIPPOVA OT, Boecking K, Broach V, Gardner GJ, et al
   Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study.
   Gynecol Oncol. 2024;187:80-84.
   PubMed         Abstract available
   
   

   
   Int J Cancer

6. HUANG C, Bu H, Wang Y, Chu R, et al
   Association between coffee and tea consumption and ovarian cancer incidence: A prospective analysis in the PLCO dataset.
   Int J Cancer. 2024 May 11. doi: 10.1002/ijc.34982.
   PubMed         Abstract available
   
   

   
   Int J Gynaecol Obstet

7. MUTCH D, Gaffney D, Matias-Guiu X, Fotopoulou C, et al
   Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
   Int J Gynaecol Obstet. 2024 Mar 21. doi: 10.1002/ijgo.15478.
   PubMed        
   
   
8. SEGOVIA JM, Cantor EA, Vargas HA, Sanabria DE, et al
   Letter to the Editor: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
   Int J Gynaecol Obstet. 2024 Mar 21. doi: 10.1002/ijgo.15475.
   PubMed        
   
   
9. WANG J, Du Y, Kang Y
   Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study.
   Int J Gynaecol Obstet. 2024 Jan 11. doi: 10.1002/ijgo.15338.
   PubMed         Abstract available
   
   

   
   Int J Oncol

10. FU M, Deng F, Chen J, Fu L, et al
    Current data and future perspectives on DNA methylation in ovarian cancer (Review).
    Int J Oncol. 2024;64:62.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

11. HARRIS HR, Davis CP, Terry KL
    Epidemiologic Methods to Advance Our Understanding of Ovarian Cancer Risk.
    J Clin Oncol. 2024 May 15:JCO2400602. doi: 10.1200/JCO.24.00602.
    PubMed        
    
    

    
    Nat Med

12. WU X, Liu J, Wang J, Wang L, et al
    Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial.
    Nat Med. 2024 May 15. doi: 10.1038/s41591-024-03003.
    PubMed         Abstract available
    
    

    
    Oncogene

13. ZHANG C, Xu Y, Zhu X, Zhang X, et al
    Phosphorylation of FOXK2 at Thr13 and Ser30 by PDK2 sustains glycolysis through a positive feedback manner in ovarian cancer.
    Oncogene. 2024 May 11. doi: 10.1038/s41388-024-03052.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.